Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Gilead Sciences Ltd
Flowers Building, Granta Park, Abington, Cambridge, Cambridge, CB21 6GT, UK
Telephone: +44 (0)1223 897 300
Fax: +44 (0)1223 897 291
Medical Information Direct Line: +44 (0)1223 897 555
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)1223 897 400
Medical Information Fax: +44 (0)1223 897 281

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 18/08/2011
PIL Emtriva 200 mg hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to dosage and administration
Updated on 09/06/2011 and displayed until 18/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 14/09/2010 and displayed until 09/06/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to side-effects
Updated on 05/01/2009 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Addition of Marketing Authorisation Holder
Updated on 09/06/2008 and displayed until 05/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/09/2007 and displayed until 09/06/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/03/2007 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 05/03/2007 and displayed until 29/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/09/2006 and displayed until 05/03/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/05/2006 and displayed until 01/09/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/06/2005 and displayed until 05/05/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/01/2005 and displayed until 07/06/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 25/08/2004 and displayed until 05/01/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to storage instructions
  • Change to Further Information section
Updated on 06/01/2004 and displayed until 25/08/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  emtricitabine